Reampla

About this medicine

Originator: Ibrance by Pfizer · Manufacturer: Pfizer Inc.. Indication & Dosage: Reampla (Palbociclib), generic Ibrance is a prescription medicine used to treat hormone receptor (HR) positive, human epidermal growth factor receptor 2 (HER2) negative advanced breast cancer in women who have experienced menopause. Reampla manufactured by Pfizer Pharma Ltd. in Germany. Palbociclib has to take orally once a day with food for 21 consecutive days followed by 7 days off treatment to comprise a complete cycle of 28 days. Side Effects: The most common adverse reaction of Palbociclib are: Nausea , vomiting , loss of appetite , diarrhea , tiredness , weakness, hair loss, mouth sores, or numbness/tingling of arms/legs. The above information comes from the Internet. Please consult with doctor for medical advice.

This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.